NVCT: Nuvectis Pharma, Inc. Stock

by  •  • Comments Off on NVCT: Nuvectis Pharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 121.52
Enterprise Value ($M) 102.05
Book Value ($M) 14.02
Book Value / Share 0.76
Price / Book 8.67
NCAV ($M) 14.02
NCAV / Share 0.76
Price / NCAV 8.67

Profitability (mra)
Return on Invested Capital (ROIC) -1.60
Return on Assets (ROA) -0.90
Return on Equity (ROE) -1.10

Liquidity (mrq)
Quick Ratio 3.46
Current Ratio 3.46

Balance Sheet (mrq) ($M)
Current Assets 19.71
Assets 19.71
Liabilities 5.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -22.90
Net Income -22.26

Cash Flow Statement (mra) ($M)
Cash From Operations -15.95
Cash from Investing 0.00
Cash from Financing 15.09

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-28 13G/A Mosseri Marlio Charles 15.00 9.03
02-06 13G Pontifax Management 4 G.p. (2015) Ltd. 5.30
02-01 13G/A Shemesh Shay 8.60 23.72
02-01 13G/A Poradosu Enrique 8.70 23.43
01-31 13G/A Peters Thomas Phineas 5.20 -4.13

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q 315603 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 3,786 19,911 19.01
2024-07-25 4,547 30,376 14.97
2024-07-24 6,176 31,653 19.51
2024-07-23 2,725 9,689 28.12
2024-07-22 4,126 14,951 27.60

(click for more detail)

Similar Companies
NRSN – NeuroSense Therapeutics Ltd. NRXP – NRx Pharmaceuticals, Inc.
NTBL – Notable Labs, Ltd. OCEA – Ocean Biomedical, Inc.
OCGN – Ocugen, Inc.


Financial data and stock pages provided by
Fintel.io